2.Dislocation of the Globe into the Nasal Cavity after Orbital Wall Fracture.
Kwang Hyun KIM ; Young AHN ; Jun Sun RYU ; Chang Bae YOON
Journal of the Korean Ophthalmological Society 2000;41(12):2765-2770
No Abstract Available.
Dislocations*
;
Nasal Cavity*
;
Orbit*
4.Cryosuperna. tant for the Therapeutic Plasma Exchange in Hemolytic Uremlc Syndrome: The Characteristics of Home-made Cryosupernatant.
Sun Hee KIM ; Dae Won KIM ; Woo In LEE ; Kwang Hyun RYU ; Chang Seok KI ; Ha Young OH
Korean Journal of Blood Transfusion 1996;7(2):187-195
Cryosupernatant which is the residual plasma fraction after removing cryoprecipitate has been used for plasma exchange in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome replacing the fresh frozen plasma. Recently, the unusually large yon Willebrand factor multireefs (ULvWFM) has been observed in patients with refractory or chronic relapsing hemolytic uremic syndrome as well as thrombotic thrombocytopenic purpura which disappeared by infusion or plasma exchange with cryosupernatant, and infusion of fresh frozen plasma, the largest multimers of yon Willebrand factor were replenished that it might be a cause of refractoriness. This study was conducted to investigate the characteristics of home-made cryosupernatant from thawed fresh frozen plasma and its thehrapeutic effect in a hemolytic uremic syndrome patient. The level of fibrinogen, coagulation factor VIII, vWF antigen, and ristocetin cofactor activity was decreased and yon Willebrand factor multimers were barely seen in cryosupernatant than those of in fresh frozen plasma. A hemolytic uremic syndrome patient tried with exchange and infusion of cryosupernatant showed excellent recovery. It is concluded that home-made cryosupernatant shares many of the features of fresh frozen plasma except factor VIII, especially von Willebrand factor multimers, and thus it could be a useful alternative to fresh frozen plasma in case of refractory hemolytic uremic synydrome.
Factor VIII
;
Fibrinogen
;
Hemolytic-Uremic Syndrome
;
Humans
;
Plasma Exchange*
;
Plasma*
;
Purpura, Thrombotic Thrombocytopenic
;
von Willebrand Factor
5.A Case of Ischemic Angina with Heart Failure due to Congenital Coronary Aterial Anomaly.
Kwang Won RYU ; Sin Bae JOO ; Seung Min CHOI ; Young Jin JOO ; Young Jin KIM ; Hong Sun LEE
Journal of the Korean Geriatrics Society 2003;7(3):243-251
Coronary artery fistula is an unusual anomaly in elderly patients that consists of a communication bet- ween one of the coronary arteries and other cardiac chambers or veins. It causes many cardiac compli- cations due to hemodynamic changes, and thus has recognized its clinical significance. It occurs usually in congenital origin, but also occurs secondarily in traumatic or neoplastic or artherosclerotic coronary diseases. Congenital coronary artery fistula is a very rare congenital anomaly that results in multiple hemodynamic complications. It has reported rarely in elderly patients, that induces myocardial ischemia due to coronary steal syndrome and heart failure that caused by diastolic volume overload via a left to left shunt. We observed a 68-year-old male patient with exertional chest pain and dyspnea, in whom selective coronary angiography revealed abnormal reticular communication between left anterior descending artery and left circumflex artery and drained to left ventricle through multiple microfistulous channels. We report this patient case who complicated by myocardial ischemia and left ventricular failure those caused by hemodynamic complication due to multiple coronary artery-left ventricular fistulae.
Aged
;
Arteries
;
Cations
;
Chest Pain
;
Coronary Angiography
;
Coronary Disease
;
Coronary Vessels
;
Dyspnea
;
Fistula
;
Heart Failure*
;
Heart Ventricles
;
Heart*
;
Hemodynamics
;
Humans
;
Male
;
Myocardial Ischemia
;
Veins
6.A Case of Ischemic Angina with Heart Failure due to Congenital Coronary Aterial Anomaly.
Kwang Won RYU ; Sin Bae JOO ; Seung Min CHOI ; Young Jin JOO ; Young Jin KIM ; Hong Sun LEE
Journal of the Korean Geriatrics Society 2003;7(3):243-251
Coronary artery fistula is an unusual anomaly in elderly patients that consists of a communication bet- ween one of the coronary arteries and other cardiac chambers or veins. It causes many cardiac compli- cations due to hemodynamic changes, and thus has recognized its clinical significance. It occurs usually in congenital origin, but also occurs secondarily in traumatic or neoplastic or artherosclerotic coronary diseases. Congenital coronary artery fistula is a very rare congenital anomaly that results in multiple hemodynamic complications. It has reported rarely in elderly patients, that induces myocardial ischemia due to coronary steal syndrome and heart failure that caused by diastolic volume overload via a left to left shunt. We observed a 68-year-old male patient with exertional chest pain and dyspnea, in whom selective coronary angiography revealed abnormal reticular communication between left anterior descending artery and left circumflex artery and drained to left ventricle through multiple microfistulous channels. We report this patient case who complicated by myocardial ischemia and left ventricular failure those caused by hemodynamic complication due to multiple coronary artery-left ventricular fistulae.
Aged
;
Arteries
;
Cations
;
Chest Pain
;
Coronary Angiography
;
Coronary Disease
;
Coronary Vessels
;
Dyspnea
;
Fistula
;
Heart Failure*
;
Heart Ventricles
;
Heart*
;
Hemodynamics
;
Humans
;
Male
;
Myocardial Ischemia
;
Veins
7.Effect of fibrin adhesive on healing of full-thickness wounds in the rat's hard palate
Kwang Sub SO ; Hong Ran CHOI ; Sun Youl RYU
Journal of the Korean Association of Maxillofacial Plastic and Reconstructive Surgeons 1998;20(4):355-361
Animals
;
Bandages
;
Fibrin Tissue Adhesive
;
Fibrin
;
Humans
;
Inflammation
;
Male
;
Palate, Hard
;
Rats
;
Splints
;
Wound Healing
;
Wounds and Injuries
8.Diagnosis and Treatment of Sacral Asymlocation in Back Pain Patients: Clinical Application of Prolotherapy.
Hyeun Sung KIM ; Ki Ho JUNG ; In Ho PARK ; Jae Kwang RYU ; Kwang Jin SUN ; Kyung Joon LIM ; Dae Hyun JO
The Korean Journal of Pain 2007;20(2):130-137
BACKGROUND: We evaluated the role and effects of prolotherapy in patients presenting with lower back pain and detected sacral asymlocation, by retrospectively analyzing the results of prolotherapy performed at our institute. METHODS: Twenty-three patients with referred pain in the lower back rather than distinct radiculopathy, were detected to have sacral asymlocation by simple X-ray from May 2004 through July 2005. The patients were treated with prolotherapy and manipulation by the Ongley's method around the lumbosacral junction, iliolumbar ligament, and sacroiliac joint. They were treated for approximately one to two week intervals, and during this period were rechecked by X-ray and evaluated using the visual analogue scale (VAS). RESULTS: A total of 23 patients were included in the study (10 male and 13 female), and the average age was 41 years. The average VAS at the time of visit was 8.5, the average treatment time was 4.7 days, and the average VAS after treatment was 2.1. CONCLUSIONS: Back pain, and associated leg and buttock pain, originate from several causes. In these case analyses, instability around the lumbosacral area and sacral asymlocation might have been important causes of patient back pain and associated buttock and leg pain. We therefore applied prolotherapy as well as manipulation techniques devised by Ongley to these patients, and obtained good results.
Back Pain*
;
Buttocks
;
Diagnosis*
;
Humans
;
Leg
;
Ligaments
;
Low Back Pain
;
Male
;
Pain, Referred
;
Radiculopathy
;
Retrospective Studies
;
Sacroiliac Joint
9.The Prevalence of Risk Factors for Vascular Disease in Parkinson's Disease; Comparison with Normal Controls and Disease Controls.
In Uk SONG ; Sun Young RYU ; Kwang Soo LEE ; Ji Yeon YOO ; Yeong In KIM ; Hee Tae KIM ; Joong Seok KIM
Journal of the Korean Geriatrics Society 2006;10(4):296-300
Background: Data on the relationship between Parkinson's disease (PD) and stroke have been conflicting, some studies showing a reduced risk of stroke during life because of low prevalence of vascular risk factors, and others indicating an increased risk of strokerelated death. The objective of this study is to determine the frequency of vascular risk factors in PD in relation to an unaffected control group and ischemic stroke patient group. Methods: We performed a case-control study on 206 consecutive PD patients, 207 ischemic strokes patients (served as "Disease" controls) and 138 age and sex matched normal subjects (served as controls), calculating multivariate risk estimates (odd ratio) for a series of established risk factors for vascular disease. Results: We found that (1) cigarette smoking (smoker, 0.078, CI=0.034-0.178; ex-smoker, 0.031, CI=0.011-0.088), and diabetes mellitus (0.340, CI=0.169-0.682) were significant less frequent in PD patients than controls, (2) cigarette smoking (smoker, 0.230, CI= 0.094-0.561; ex-smoker, 0.132, CI=0.050-0.348), hypertension (0.283, CI=0.175-0.459), diabetes mellitus (0.257, CI=0.136-0.486), previous stroke (0.063, CI=0.020-0.191), heart disease (0.344, CI=0.176-0.673) than ischemic stroke patients, respectively. Conclusion: We found the significant negative association of a series of vascular factors with PD, indicating a protective effect of PD against ischemic stroke.
Case-Control Studies
;
Diabetes Mellitus
;
Heart Diseases
;
Humans
;
Hypertension
;
Parkinson Disease*
;
Prevalence*
;
Risk Factors*
;
Smoking
;
Stroke
;
Vascular Diseases*
10.1alpha,25-Dihydroxyvitamin D3 Protects Dopaminergic Neurons in Rodent Models of Parkinson's Disease through Inhibition of Microglial Activation.
Joong Seok KIM ; Sun Young RYU ; Injin YUN ; Woo Jun KIM ; Kwang Soo LEE ; Jeong Wook PARK ; Yeong In KIM
Journal of Clinical Neurology 2006;2(4):252-257
BACKGROUND: Recent studies have demonstrated the molecular basis of the immunomodulatory and anti-inflammatory activities of 1,25-dihydroxyvitamin D3(1,25-(OH)2D3). This hormone improves behavioral deficits and normalizes the nigral dopamine levels in animal models of Parkinson's disease (PD). METHODS: We studied whether the administration of 1,25-(OH)2D3 would protect against 6-hydroxydopa (6-OHDA)- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neuronal injury, and its potential regulatory effect on microglia activation. RESULTS: We found that 1,25-(OH)2D3 pretreatment significantly decreased 6-OHDA- and MPTP-induced dopaminergic neuronal loss in the substantia nigra pars compacta by preventing the activation of microglia. This observed neuroprotective effect in MPTP-treated mice that were given 1,25-(OH)2D3 may be attributable to inhibition of proinflammatory cytokine expression. CONCLUSION: These results suggest that 1,25-(OH)2D3 is a potentially valuable neuroprotective agent; it may therefore be considered for the treatment of pathologic conditions of the central nervous system, such as PD, where inflammation-induced neurodegeneration occurs.
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
;
Animals
;
Central Nervous System
;
Dopamine
;
Dopaminergic Neurons*
;
Inflammation
;
Mice
;
Microglia
;
Models, Animal
;
Neurons
;
Neuroprotective Agents
;
Parkinson Disease*
;
Rats
;
Rodentia*
;
Substantia Nigra
;
Vitamin D